2017 Publication

Temozolomide in the Era of Precision Medicine. Cancer Res. 2017 Feb 15. [Epub ahead of print].
Thomas A, Tanaka M, Trepel J, Reinhold WC, Rajapakse VN, Pommier Y.

Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay.Plos One. 2017 Feb 3.
Ji J, Zhang Y, Redon CE, Reinhold WC, Chen AP, Fogli LK, Holbeck SL, Parchment RE, Hollingshead M, Tomaszewski JE, Dudon Q, Pommier Y, Doroshow JH, Bonner WM.

The NCI-60 Methylome and its Integration into CellMiner. Cancer Res. 2017 Feb 1. pii: [Epub ahead of print].
Reinhold WC, Varma S, Sunshine M, Rajapakse V, Luna A, Kohn KW, Stevenson H, Wang Y, Heyn H, Nogales V, Moran S, Goldstein DJ, Doroshow JH, Meltzer PS, Esteller M, Pommier Y.

Cytidine deaminase deficiency reveals new therapeutic opportunities against cancer. Clin Cancer Res. 2017 Apr 15. pii: clincanres.0626.2017. [Epub ahead of print].
Mameri H, Bieche I, Meseure D, Marangoni E, Buhagiar-Labarch�de G, Nicolas A, Vacher S, Onclercq-Delic R, Rajapakse V, Varma S, Reinhold WC, Pommier Y, Amor-Gu�ret M.